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Abstract
Background: Animal and human studies suggest that inflammation and malnutrition are common in acute kidney
injury (AKI) patients. However, only a few studies reported CRP, a marker of inflammation, albumin, prealbumin and
cholesterol, markers of nutritional status were associated with the prognosis of AKI patients. No study examined
whether the combination of inflammatory and nutritional markers could predict the mortality of AKI patients.
Methods: 155 patients with hospital-acquired AKI were recruited to this prospective cohort study according to
RIFLE (Risk, Injury, Failure, Lost or End Stage Kidney) criteria. C-reactive protein (CRP), and the nutritional markers
(albumin, prealbumin and cholesterol) measured at nephrology consultation were analyzed in relation to all cause
mortality of these patients. In addition, CRP and prealbumin were also measured in healthy controls (n = 45),
maintenance hemodialysis (n = 70) and peritoneal dialysis patients (n = 50) and then compared with AKI patients.
Results: Compared with healthy controls and end-stage renal disease patients on maintenance hemodialysis or
peritoneal dialysis, patients with AKI had significantly higher levels of CRP/prealbumin (p < 0.001). Higher level of
serum CRP and lower levels of albumin, prealbumin and cholesterol were found to be significant in the patients
with AKI who died within 28 days than those who survived >28 days. Similarly, the combined factors including the
ratio of CRP to albumin (CRP/albumin), CRP/prealbumin and CRP/cholesterol were also significantly higher in the
former group (p < 0.001 for all). Multivariate analysis (Cox regression) revealed that CRP/prealbumin was
independently associated with mortality after adjustment for age, gender, sepsis and sequential organ failure
assessment (SOFA, p = 0.027) while the others (CRP, albumin, prealbumin, cholesterol, CRP/albumin and CRP/
cholesterol) became non-significantly associated. The hazard ratio was 1.00 (reference), 1.85, 2.25 and 3.89 for CRP/
prealbumin increasing according to quartiles (p = 0.01 for the trend).
Conclusions: Inflammation and malnutrition were common in patients with AKI. Higher level of the ratio of CRP to
prealbumin was associated with mortality of AKI patients independent of the severity of illness and it may be a
valuable addition to SOFA score to independent of the severity of illness and it may be a valuable addition to
SOFA score to predict the prognosis of AKI patients.
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Background
Acute kidney injury (AKI) is well-known associated with
increased mortality of in hospital patients. Although
great advances in diagnosis of AKI have been made, the
mortality remains high [1-5]. Among the patients with
AKI, inflammation and malnutrition were common
[6,7], but there were only a few studies suggested that
inflammation and malnutrition were associated with the
prognosis of AKI patients [7,8].
Serum C reactive protein (CRP) was an acute-phase pro-
tein synthesized by the liver following stimulus by various
cytokines, markedly increased within hours after infection
or inflammation. The relatively short half-life of approxi-
mately 19 hours makes it a useful monitor for infection
and inflammatory disease. In addition, laboratory tests for
CRP are easily available and less costly than cytokine tests
[9-11]. Some studies suggested that increased CRP level
was associated with sepsis and mortality of critical illness
[9]. However, no study demonstrated that CRP was a pre-
dictor for mortality of AKI patients [12]. Malnutrition was
another outstanding problem in AKI patients and has been
paid attention to in recent years [13-16]. According to the
International Society of Renal Nutrition and Metabolism
(ISRNM), the serum chemistry markers including albumin,
prealbumin and cholesterol are recommended to assess the
nutritional status [17]. Chertow et al reported that prealbu-
min is as important as albumin in the nutritional assess-
ment of hemodialysis patients [18]. The study by Cano et
al showed that an improvement in prealbumin during
nutritional therapy was associated with a decrease in mor-
bidity and mortality in malnourished hemodialysis patients
[19]. Another study also reported that even though baseline
serum prealbumin may not be superior to albumin in pre-
dicting mortality in maintenance hemodialysis (MHD)
patients, prealbumin concentrations <20 mg/dL were asso-
ciated with death risk in those patients and a fall in serum
prealbumin over 6 month was independently associated
with increased death risk [20]. In AKI patients, Perez-
Valdivieso et al found that serum prealbumin levels
<11 mg/dL were strongly associated with a higher risk of
death independent of AKI severity [21]. Besides, few stu-
dies reported the predict value of prealbumin in AKI
patients. Cholesterol is another nutritional biomarker
wildly used in clinic. In 1994, Dunham et al found that
patients with severe trauma had a sudden reduction in
total serum cholesterol concentration [22]. Hypocholester-
olemia has been observed in patients undergoing surgical
interventions and in those with multiple-organ dysfunction
syndrome [23,24]. However, few studies showed the asso-
ciation between cholesterol and the prognosis of AKI
patients. In addition, the correlation between inflammation
and malnutrition was close and complex because inflam-
mation could lead to malnutrition, as well as malnutrition
was an adverse factor for the control of inflammation [15].
Pinilla et al reported that the ratio of CRP to prealbumin
(CRP/prealbumin) was associated with the severity of
organ dysfunction in critically ill patients [25]. However, no
study reported that the combination of the inflammatory
and nutritional markers could predict the mortality of AKI
patients. The aim of our study was to investigate the corre-
lation between inflammatory marker (CRP), nutritional
markers (albumin, prealbumin and cholesterol) and 90
days mortality of AKI patients. We also studied the combi-
nation of inflammatory and nutritional markers including
the ratio of CRP to albumin (CRP/albumin), CRP/prealbu-
min and CRP/cholesterol as tools to assess the risk for
death in patients with AKI.
Methods
Subjects
We prospectively studied a random cohort of adult
patients with hospital-acquired acute kidney injury (AKI)
from December 2008 to November 2009 at Huashan hos-
pital affiliated to Fudan university, a tertiary hospital
including 30 wards, comprising 1500 beds in the city of
Shanghai, China. AKI was determined using the RIFLE
(Risk, Injury, Failure, Loss, or End stage kidney) staging
criteria for changes in the serum creatinine within one
week [26]. In brief, a RIFLE risk was defined by a 50%
rise in creatinine, RIFLE injury by a doubling of baseline
creatinine, and RIFLE failure by 3 folds increase of base-
line creatinine. In-patient’s serum creatinine data were
monitored in our hospital’s information system daily.
Patients with creatinine levels rising within one week in
accordance with RIFLE criteria were consulted by
nephrologists within 24 hours. Those with AKI caused by
post-renal obstruction, glomerulonephritis, interstitial
nephritis or vasculitis, etc were excluded from the study.
Patients were followed prospectively from the time of
nephrology consultation until death. The observational
period was 3 months and the primary outcome was all-
cause mortality. We also compared results obtained in
AKI patients with healthy controls (n = 45) and end-
stage renal disease (ESRD) patients on maintenance
hemodialysis (n = 55) or continuous ambulatory perito-
neal dialysis (n = 50). The healthy control was randomly
selected in healthcare center of Huashan Hospital, and
the stable MHD patients and PD patients were randomly
selected from hemodialysis center or peritoneal dialysis
center of Huashan Hospital. The study was approved by
the ethics committee of Huashan Hospital, Fudan
University (approval number: 2009-097). All patients
gave written informed consent.
Clinical Data
In the first 24 hours after AKI was diagnosed, the vari-
ables including demographic data, presence of sepsis,
need for mechanical ventilation, AKI pathogenesis
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(ischemic, nephrotoxic or multifaceted), comorbidity
conditions, primary and concomitant diagnoses were
recorded.
The severity of illness was evaluated according to the
sequential organ failure assessment (SOFA) score [27].
The SOFA score included six systems which were
respiratory, cardiovascular, neurologic, renal, hematolo-
gic and hepatic system. Organ failure was defined as a
score of ≥3 for each. Sepsis was defined when the
patient met their criteria for systemic inflammatory
response syndrome (SIRS) and simultaneously presented
with a documented or a suspected infection. Infection
was diagnosed according to usual clinical, laboratory
and microbiological parameters. The criteria for SIRS
derived from 1992 the American College of Chest Physi-
cians/Society of Critical Care Medicine Consensus Con-
ference [28].
Blood samples
The samples for measurement were fasting blood and
obtained within 24 hours after AKI diagnosis, pre-dialysis
for maintenance hemodialysis patients and random for
peritoneal patients and healthy controls. The blood was
collected in serum-separating tubes and the serum was
separated within 30 min of sample collection, and then
aliquoted and stored at -80°. CRP were measured by
nephelometry immunoassay, the detectable limit of CRP
was 0.316 mg/dL. The levels of CRP below the detectable
limit were assumed as 0.158 mg/dL. Serum albumin, pre-
albumin and cholesterol were measured using the auto-
matic biochemistry analyzer.
Statistical analysis
Continuous variables were expressed as mean ± SD or
median with range of quartile, and categorical variables
were expressed as percentage. In univariate analysis, com-
parisons between groups were analyzed using independent
t test or Mann-Whitney U test for continuous variables,
and Pearson chi test or Fisher exact test for categorical
variables. In multivariate analysis, Cox proportional
hazards regression was used to identify independent pre-
dictors of mortality in AKI patients. Covariates including
age, gender, sepsis and SOFA were used for stepwise
adjustment. The Hazard ratio (HR) for death was
expressed per 2 mg/dL increase in CRP, 5 mg/dL decrease
in prealbumin, 0.5 g/dL decrease in albumin, 3 mg/dL
decrease in cholesterol, 0.1 increase in CRP (mg/dL)/preal-
bumin (mg/dL), 1 increase in CRP (mg/dL)/albumin
(g/dL), 0.1 increase in CRP (mg/dL)/cholesterol (mg/dL).
The Kaplan-Meier survival curve at 90 days was used
to evaluate the difference between the 2 groups which
were divided according to the median of CRP/prealbu-
min value, and compared using log-rank test. The time
of origin was the day when nephrology consultation
began. The event was defined death and the cases lost
to follow-up were censored at their last observation. All
statistical tests were 2-sided, and differences were con-
sidered statistically significant with p value < 0.05.
Results
Patient characteristics
A total of 155 AKI patients with mean age (±SD) 63.4
(±18.4) years were enrolled into this study, and 74.2% of
which were male. The predominant comorbidities were
as follows: hypertension in 66 patients (44.60%), diabetes
in 25 patients (16.9%) and CKD in 10 patients (6.8%).
The basic serum creatinine was 0.9 (0.7-1.1) mg/dL and
raised to 1.9 (1.5-2.7) mg/dL when AKI was diagnosed
according to RIFLE staging with risk 71 patients (45.8%),
injury 38 patients (24.5%) and failure 46 patients (29.7%).
The etiologies of AKI were ischemia (42.6%), nephrotoxi-
city (20.0%), and multifaceted factors (37.4%). Of the 155
patients with AKI, 67 patients (43.8%) suffered from sep-
sis, 31 patients (20.0%) needed ventilation and 30 patients
(19.4%) needed dialysis during the following period. The
SOFA score which indicated the severity of illness was
7 (4-11). The overall 28 days mortality was 33.5%.
Table 1 also displayed the demographic and clinical
features of survivors (n = 103) and non-survivors (n =
52) which were grouped according to the survival status
at 28 days. There were no significant differences in age,
gender, basic serum creatinine, RIFLE criteria and etiol-
ogy of AKI between the the two groups. The comparison
showed that survival group had higher rate of CKD his-
tory but lower serum creatinine level when AKI diag-
nosed. Unsurprising, the median of SOFA score as
assessed at the time of nephrology consultation were sig-
nificantly higher in the non-survival group (p < 0.001).
During the course of the study, the need for ventilation
was less among survivors (11.7% vs. 36.5%, p < 0.001)
while the need for renal replacement therapy was similar
in the two groups (17.5% of survivors vs. 23.1% of non-
survivors, p = 0.405). No differences were also found in
white blood cell count, bilirubin and hemoglobin.
The inflammatory and nutritional markers and their
relationship with mortality of AKI patients
CRP, albumin, prealbumin and cholesterol determined
from blood obtained within 24 hours of AKI diagnosis
were displayed in table 2. CRP, reflecting the inflamma-
tion status, was elevated in non-survivors compared
with the survivors (6.6 (1.9 to 11.9) vs. 3.8 (1.2 to 11.4)
mg/dL, p = 0.001). On the contrary, albumin, prealbu-
min and cholesterol which reflecting the nutritional sta-
tus were all significantly lower in non-survivors (3.1 ±
0.6 vs. 3.3 ± 0.7 mg/dL, p = 0.025 for albumin; 12.5 ±
5.9 vs. 16.4 ± 6.9 mg/dL, p = 0.001 for prealbumin; 12.2
± 5.0 vs. 14.5 ± 6.1 mg/dL, p = 0.020 for cholesterol).
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Further analysis showed that the combined factors
including CRP/albumin, CRP/prealbumin and CRP/cho-
lesterol were all significantly higher in non-survivors
when compared with the survivors (p < 0.001).
In multivariable analysis of these selected possible pre-
dictors for mortality of AKI patients, we controlled the
demographic factors including age and gender as model
1, controlled age, gender and sepsis as model 2, con-
trolled age, gender and SOFA as model 3, controlled
age, gender, sepsis and SOFA as model 4. Table 3
showed that when adjusted for the severity of illness
(SOFA), CRP/prealbumin remained an independent pre-
dictor of mortality (p = 0.027) while the others were no
longer independently associated. Hazard ratio was 1.037
per 0.1 increases for CRP/prealbumin when adjusted for
age, gender, sepsis and SOFA. Figure 1 illustrates the
risk profiles for CRP/prealbumin according to quartiles.
The values for CRP/prealbumin above the 25th percen-
tile were associated with a progressively higher risk of
mortality after adjusting for age and gender (p = 0.01
for the trend). We also used the median of CRP/preal-
bumin as cut-off point to divide the patients into 2
groups and made the Kaplan-Meier plot (Figure 2)
which showed that the survival of patients with CRP/
prealbumin >0.42 was significantly worse than that of
patients with lower levels (log rank test, p < 0.01). At
Table 1 Demographic and clinical data of patients at the time of acute kidney injury diagnosis
Total (n = 155) Survivors (n = 103) Non-survivors (n = 52) p value
Age 63.4 ± 18.4 63.96 ± 19.04 62.2 ± 17.1 0.577
Gender (male) 115(74.2%) 78 (75.7%) 37 (71.2%) 0.539
Basic Scr(μmol/L) 79.5 (61.0-100.0) 78.5 (61.3-98.5) 80.5 (58.8-102.0) 0.501
Scr when AKI diagnosed (μmol/L) 165 (132-237) 158 (126-216) 190.5 (142.5-241.5) 0.030
RIFLE criteria (%) 0.235
Risk 71 (45.8%) 50 (48.5%) 21 (40.4%)
Injury 38 (24.5%) 27 (26.2%) 11 (21.2%)
Failure 46 (29.7%) 26 (25.2%) 20 (38.5%)
Etiology of AKI 0.513
Ischemic 66 (42.6%) 44 (42.7%) 22 (42.3%)
Multifaceted 58 (37.4%) 36 (35.0%) 22 (42.3%)
Nephrotoxic 31 (20.0%) 23 (22.3%) 8 (15.4%)
Comorbidity
Hypertension 66 (44.6%) 40 (40.8%) 26 (52.0%) 0.195
Diabetes 25 (16.9%) 19 (19.4%) 6 (12.0%) 0.257
CKD 10 (6.8%) 10 (10.2%) 0 (0%) 0.017
Sepsis 67 (43.8%) 41 (40.2%) 26 (51.0%) 0.205
Ventilation 31 (20.0%) 12 (11.7%) 19 (36.5%) <0.001
Dialysis 30 (19.4%) 18 (17.5%) 12 (23.1%) 0.405
Hemoglobin (g/dL) 11.2 (9.6-12.6) 11.2 ± 2.0 10.7 ± 3.1 0.265
WBC (103/mm3) 11.2 (7.7-16.5) 10.8 (7.1-16.9) 12.1 (9.2-16.4) 0.222
TB (mmol/L) 12.0 (8.2-21.2) 12.0 (8.0-18.5) 13.0 (8.5-28.4) 0.112
SOFA 7 (4-11) 4 (3-7) 12.5 (9.3-15.0) <0.001
Data were divided into two groups according to survival status of 28 days.
Abbreviations: Scr: serum creatinine; AKI, acute kidney injury; CKD, chronic kidney disease; WBC, white blood cell; TB: Total bililubin; SOFA, sequential organ
failure assessment.
Table 2 Univariate analysis of selected possible predictors of mortality in patients with AKI
Total survivors nonsurvivors p value
Albumin (g/dL) 3.2 ± 0.7 3.3 ± 0.7 3.1 ± 0.6 0.025
Prealbumin (mg/dL) 15.1 ± 6.8 16.4 ± 6.9 12.5 ± 5.9 0.001
Cholesterol (mg/dL) 13.9 ± 5.8 14.5 ± 6.1 12.2 ± 5.0 0.020
CRP (mg/dL) 6.6 (1.9-11.9) 3.8 (1.2-11.4) 10.6 (3.1-15.1) 0.001
CRP: Albumin (mg/dL: g/dL) 1.97 (0.56-4.17) 1.36 (0.35-3.57) 3.57 (0.94-5.18) 0.001
CRP: Prealbumin (mg/dL: mg/dL) 0.42 (0.11-1.13) 0.34 (0.07-0.84) 1.04 (0.22-1.55) <0.001
CRP: Cholesterol (mg/dL: mg/dL) 0.53 (0.13-1.06) 0.38 (0.07-0.80) 0.87 (0.30-1.46) <0.001
Abbreviation: CRP, C reactive protein.
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the end of the follow-up period, the mortality was
remarkably higher in the CRP/prealbumin >0.42 group
(63.4% vs. 38.7%, p = 0.026).
The ratio of CRP to prealbumin dramatically increased in
patients with AKI
Patients with AKI had marked increase in serum CRP
levels and decrease in prealbumin simultaneously when
compared with healthy control subjects (6.56 vs.
0.16 mg/dL for median of CRP, p < 0.001; 15.1 ± 6.8
vs. 25.8 ± 5.5 mg/dL for prealbumin, p < 0.001). Simi-
larly, the value of CRP was 10- to 20- fold higher in
the AKI patients compared with ESRD patients on
maintenance hemodialysis or peritoneal dialysis. The
prealbumin levels in the AKI patients were also signifi-
cantly lower than ESRD patients (29.9 ± 5.9 mg/dL for
MHD patients; 31.1 ± 8.5 mg/dL for PD patients). As
illustrated in figure 3, the CRP/prealbumin was also
dramatically increased in AKI patients (p < 0.001).
Discussion
The aim of this study was to assess whether serum
inflammatory and nutritional markers can predict mor-
tality in a cohort of patients with AKI. The inflamma-
tory marker CRP, the nutritional markers including
albumin, prealbumin, cholesterol and their ratio includ-
ing CRP/albumin, CRP/prealbumin, CRP/cholesterol
were analyzed. The results showed that after adjusting
for gender and age, all of the markers were associated
with the 90 days mortality in these patients. However,
when further adjustment was done for the severity of ill-
ness, only CRP/prealbumin remained significant. We
then used the median of CRP/prealbumin in this cohort
as the cut-off point to separate patients into two groups
Table 3 Multivariate Cox regression analysis for the selected possible predictors of mortality in patients with AKI
CRP (mg/L) prealbumin (mg/dL) CRP/prealbumin albumin (g/dL) CRP/albumin cholesterol (mg/dL) CRP/cholesterol
HR p HR p HR p HR p HR p HR p HR p
unadjusted 1.108 0.006 1.404 0.002 1.057 0.000 1.185 0.075 1.128 0.022 1.154 0.043 1.039 0.001
model 1 1.123 0.003 1.398 0.002 1.059 0.000 1.185 0.083 1.137 0.017 1.166 0.041 1.043 0.001
model 2 1.121 0.005 1.404 0.002 1.058 0.000 1.166 0.121 1.132 0.027 1.171 0.034 1.043 0.001
model 3 1.052 0.285 1.100 0.407 1.037 0.023 0.974 0.785 1.029 0.653 0.947 0.453 0.993 0.633
model 4 1.051 0.320 1.099 0.414 1.037 0.027 0.967 0.737 1.027 0.681 0.949 0.470 0.991 0.588
The Hazard ratio (HR) for death was expressed per a 2 mg/dL increase in CRP, 5 mg/dL decrease in prealbumin, 0.5 g/dL decrease in albumin, 3 mg/dL decrease
in cholesterol, 0.1 increase in CRP (mg/dL)/prealbumin (mg/dL), 1 increase in CRP (mg/dL)/albumin (g/dL), 0.1 increase in CRP (mg/dL)/cholesterol (mg/dL) for a
univariate model and sequential adjustment models.
The multivariate analysis sequentially adjusted models for covariates as follows: Model 1, adjusted for age, gender; Model 2, adjusted for age, gender and sepsis;
Model 3, adjusted for age, gender and SOFA; Model 4, adjusted for age, gender, sepsis and SOFA.
Figure 1 (A) Risk profiles for CRP according to quartiles, p = 0.029 for the trend; (B) Risk profiles for prealbumin, p = 0.013 for the
trend; (C) Risk profile for CRP: prealbumin, p = 0.01 for the trend. Values along horizontal axis represent the means of CRP, prealbumin and
CRP/prealbumin of the respective quartiles. Hazard ratios of death for CRP rising, prealbumin decreasing and CRP/prealbumin rising according to
quartiles were adjusted by age and gender.
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which showed that higher CRP/prealbumin had a higher
mortality of 90 days. Such results suggested that when
AKI was diagnosed, higher levels of CRP/prealbumin in
patients with AKI indicated, at least partly, a poorer
prognosis and more aggressive diagnostic and therapeu-
tic interventions were needed to avoid complications.
Consistent with previous studies, malnutrition and
inflammation was common in our patients with AKI
[7,29]. In Fiaccadori’s study in 1999, severe malnutrition,
defined by Subjective Global Assessment (SGA) class C,
was documented in about 40% of patients [7]. According
to the International Society of Renal Nutrition and
Metabolism (ISRNM), the serum albumin <3.8 g/dL was
recommended as a main diagnostic indicator of malnu-
trition [17]. Not surprisingly, approximate 80% patients
in this cohort presented with serum albumin values <3.8
g/dL. Prealbumin is a nutritional marker used to evalu-
ate recent nutritional status with a short half-life and a
rapid synthesis rate [30-32], and it is also a negative
acute-phase protein and inverse associated with inflam-
mation. According to the Nutritional Care Consensus
Group, serum prealbumin >15 mg/dL indicates that
patients are not at risk for malnutrition [32]. There
were more than 50% patients with serum prealbumin
<15 mg/dL in our study. CRP is one of the wildly used
biomarkers for monitoring the course of infection and
inflammation [9-11]. Compared with healthy control,
MHD and PD patients, CRP in these patients with AKI
were significantly higher.
Previous studies suggested that malnutrition and inflam-
mation had a negative impact on the prognosis of AKI
patients. The meta-analysis by Wiedermann et al. provided
evidence that hypoalbuminemia is a significant indepen-
dent predictor of death following AKI development [13].
Although the phenomenon that the lower albuminemia,
the poorer prognosis was also found in our study, there
was no statistical significance in univariate analysis (p =
0.075). This was probably because the sample size of our
study was not large enough. Besides, there are only a few
studies examined the association between CRP or prealbu-
min and mortality of these subjects [8,12,21] The PICARD
study showed that there were no significant differences in
CRP levels between acute renal failure (ARF) patients who
died during hospitalization and survivals [8]. According to
Valdivieso et al., serum prealbumin levels <11 mg/dL were
strongly associated with a higher risk of death, indepen-
dent of AKI severity, comorbidities and serum CRP [21].
Differently, all of the markers including serum albumin,
prealbumin and cholesterol in the current study were not
significantly associated with the 90 mortality after adjust-
ment for the severity of illness.
Pinilla et al demonstrated a strong correlation between
the ratio of CRP to prealbumin and the severity of organ
dysfunction in critically ill patients [25]. However, the
association of CRP/prealbumin and prognosis of AKI
patients hasn’t been reported. Our study suggested that
CRP/prealbumin when AKI was diagnosed was indepen-
dently associated with mortality of these patients after
adjustment for the severity of illness. CRP/prealbumin
levels >3 having a particularly higher mortality suggested
that inflammation activity and malnutrition indicated a
poor prognosis. These data provide evidence supporting
the measurement of serum CRP/prealbumin levels may
be an inexpensive and useful tool in the evaluation of
the risk profiles of AKI patients.
Figure 2 Kaplan-Meier analysis for the cumulative percentage
of surviving patients at 90 days according to different CRP/
prealbumin levels. The median of CRP/prealbumin was used as the
cut-off point to divide the patients with AKI into 2 groups. Patients
with higher levels of CRP/prealbumin (n = 78) had a significantly
lower survival rate in these patients (log rank test, p < 0.01).
Figure 3 Levels of the ratio of CRP to prealbumin in different
populations. Healthy (n = 45); MHD: maintenance hemodialysis (n
= 70); PD: peritoneal dialysis (n = 50); AKI: acute kidney injury (n =
155). The units of CRP and prealbumin were both mg/dL. Mann-
Whitney U test was used for comparison between the populations,
p < 0.001. Horizontal bars indicate 10th, 25th, 50th (median), 75th,
and 90th percentile levels.
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In addition, 43.8% of the AKI patients suffered from
sepsis in our study. However, septic AKI obviously did
not play a role in AKI prognosis. This is different from
many previous studies. The PICARD study showed that
sepsis in AKI patients portended a poor prognosis, with
higher mortality rates and relatively longer length of
stay [33]. Different study population may contribute to
the discrepancy that our patients were not confined to
the ICU or critical ill patients. There were some limita-
tions in this study. Firstly, this was an observational, sin-
gle-center and relatively small size study, and our results
only described the association between inflammatory or
nutritional markers and 90 days mortality. Secondly, the
studied population was composed by heterogeneous
AKI patients in a tertiary comprehensive hospital. Selec-
tion bias may have influence the result. At the same
time, urinary output data were not available, so it was
not possible to estimate the RIFLE criteria according to
the values.
Conclusions
In conclusion, the present study firstly assesses the cor-
relation between CRP/prealbumin levels and the mortal-
ity in AKI patients. Lower serum CRP/prealbumin levels
were strongly associated with higher mortality after
adjusting for the severity of illness (SOFA). So it was a
good marker of mortality in these patients. In addition,
the measurement of CRP and prealbumin were inexpen-
sive and it may be a valuable addition to SOFA scores
to predict the risk of death in AKI patients.
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